Mitsubishi, Tanabe Merge To Accelerate International Business Development
This article was originally published in PharmAsia News
Executive Summary
The merger of Mitsubishi Pharma and Tanabe Seiyaku will create the fifth largest Japanese drug maker, positioning the combined company to better compete in the international market. Mitsubishi Chemical Holdings announced plans to acquire Tanabe for a reported $4.3 billion Feb. 2